RT Journal Article
SR Electronic
T1 Renal denervation: potential indications and review of trial data
JF Clinical Medicine
JO Clin Med
FD Royal College of Physicians
SP s38
OP s40
DO 10.7861/clinmedicine.14-6-s38
VO 14
IS Suppl 6
A1 Claire E Raphael
YR 2014
UL http://www.rcpjournals.org/content/14/Suppl_6/s38.abstract
AB Renal sympathetic denervation is a novel, endovascular treatment with potential utility in resistant hypertension. First pioneered in humans in 2010, conflicting data exist regarding the efficacy of this treatment. This article will review the evidence to date, the scientific rationale for sympathetic denervation as a treatment for hypertension and consider other possible conditions where the therapy may be of benefit.